Toll Free: 1-888-928-9744

2013-2028 Report on Global Follow-on Biologics Market by Player, Region, Type, Application and Sales Channel

Published: Dec, 2018 | Pages: 108 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The Global Follow-on Biologics Market is set to grow at an exponential CAGR by the year 2028 attributed to its proven results in developing bio-similar drugs for treating chronic diseases such as diabetes and cancer. Biosimilars have the potential to offer patients and physicians additional options for the treatment of serious illnesses. “Advancement of technology and the growing investment in research activities have developed more competent antibodies and biologics medicine that has potentially outperformed the prevailing biosimilars.”

The financial burden on pharmaceutical manufacturers to develop patented drugs is a major factor responsible for the hampered market growth. Emerging entrants are taking advantage of the price sensitive market space to develop cost-effective drugs and is, therefore, fueling follow-on biologics market growth. Also, the global escalation of geriatric population is further boosting the adoption of follow-on biologics products. However, an integral complication of biologics and the proprietary manufacturing process to replicate an original biologic medicine, have often posed several challenges to host optimized drug benefits.

These medicines are highly sensitive to the corresponding environmental condition that they are stored in and often affects its utility. Therefore, to achieve the productivity and reliability of this medicine, the suppliers have ensured strategies to maximize the possible capital investments.

Therapeutic submarkets of Follow-on Biologics Market include Monoclonal antibodies (mAbs), Insulin, Granulocyte colony-stimulating factor (G-CSF), Growth hormones, Fusion proteins, Erythropoietin (EPO), Interferons, and Fertility hormones. Based on application, the market has been segmented into blood disorders, growth hormone deficiencies, chronic and autoimmune diseases, oncology diseases, and others.

Many geographies have gained the official approval for commercialization of trading these products. The comprehensive overview of the Follow-on Biologics Market has identified North America, Latin America, the Middle East & Africa, Europe and Asia Pacific as the key regions. The major players have gained cost advantage in the emerging countries of Asia Pacific and Middle East & Africa to deploy lucrative follow-on biologics products. Europe was a pioneer to develop follow-on biologics guidelines in the year 2005 and was accepted as a worldwide template, which was subsequently revisited and reformed in the year 2015. An increasing assessment from financial organizations, government, and other regulatory bodies is influencing the effective research methodology and an in-depth exploration of business strategies to be adopted by the prominent market players.

Comprehensive Follow-on Biologics Market share analysis of the competitive landscape has generated highlights on leading product launches, altering market trends and futuristic opportunities in identifying key marketing pockets. They have successfully counterfeit original drugs with the help of several pre-clinical assessments, clinical trials, partnership and co-development strategies, joint ventures, etc. The leading players are keen on repositioning their strategic agendas from commercialization approvals to gain Follow-on Biologics Market capitalization. Mylan and Biocon entered into a collaboration to exercise the sale of first ever biosimilar of trastuzumab in India. In Europe, Hospira cited to commercialize the approved biosimilar version of monoclonal antibody drug. 

The global Follow-on Biologics market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Follow-on Biologics from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Follow-on Biologics market.

Leading players of Follow-on Biologics including:

•	Sandoz
•	Pfizer
•	Teva Pahrmaceutical
•	Celltrion
•	Biocon
•	Amgen
•	Samsung Biologics
•	Mylan
•	Dr. Reddy's Laboratories
•	Stada Arzneimittel AG

Market split by Type, can be divided into:

•	Recombinant Non-glycosylated Proteins
•	Recombinant Glycosylated Proteins
•	Recombinant Peptides

Market split by Application, can be divided into:

•	Oncology
•	Blood Disorders
•	Chronic Diseases
•	Autoimmune Diseases
•	Growth Hormone Deficiency
•	Infectious Diseases

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.
 Table of Contents

Chapter 1 Follow-on Biologics Market Overview
    1.1 Follow-on Biologics Definition
    1.2 Global Follow-on Biologics Market Size Status and Outlook (2013-2028)
    1.3 Global Follow-on Biologics Market Size Comparison by Region (2013-2028)
    1.4 Global Follow-on Biologics Market Size Comparison by Type (2013-2028)
    1.5 Global Follow-on Biologics Market Size Comparison by Application (2013-2028)
    1.6 Global Follow-on Biologics Market Size Comparison by Sales Channel (2013-2028)
    1.7 Follow-on Biologics Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Follow-on Biologics Market Segment Analysis by Player
    2.1 Global Follow-on Biologics Sales and Market Share by Player (2016-2018)
    2.2 Global Follow-on Biologics Revenue and Market Share by Player (2016-2018)
    2.3 Global Follow-on Biologics Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Follow-on Biologics Market Segment Analysis by Type
    3.1 Global Follow-on Biologics Market by Type
        3.1.1 Recombinant Non-glycosylated Proteins
        3.1.2 Recombinant Glycosylated Proteins
        3.1.3 Recombinant Peptides
    3.2 Global Follow-on Biologics Sales and Market Share by Type (2013-2018)
    3.3 Global Follow-on Biologics Revenue and Market Share by Type (2013-2018)
    3.4 Global Follow-on Biologics Average Price by Type (2013-2018)
    3.5 Leading Players of Follow-on Biologics by Type in 2017
    3.6 Conclusion of Segment by Type

Chapter 4 Follow-on Biologics Market Segment Analysis by Application
    4.1 Global Follow-on Biologics Market by Application
        4.1.1 Oncology
        4.1.2 Blood Disorders
        4.1.3 Chronic Diseases
        4.1.4 Autoimmune Diseases
        4.1.5 Growth Hormone Deficiency
    4.2 Global Follow-on Biologics Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Follow-on Biologics by Application in 2017
    4.4 Conclusion of Segment by Application

Chapter 5 Follow-on Biologics Market Segment Analysis by Sales Channel
    5.1 Global Follow-on Biologics Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Follow-on Biologics Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Follow-on Biologics by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Follow-on Biologics Market Segment Analysis by Region
    6.1 Global Follow-on Biologics Market Size and CAGR by Region (2013-2028)
    6.2 Global Follow-on Biologics Sales and Market Share by Region (2013-2018)
    6.3 Global Follow-on Biologics Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Follow-on Biologics Market Share by Type
        6.4.3 North America Follow-on Biologics Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Follow-on Biologics Market Share by Type
        6.5.3 Europe Follow-on Biologics Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Follow-on Biologics Market Share by Type
        6.6.3 Asia-Pacific Follow-on Biologics Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Follow-on Biologics Market Share by Type in 2017
        6.7.3 South America Follow-on Biologics Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Follow-on Biologics Market Share by Type
        6.8.3 Middle East & Africa Follow-on Biologics Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Follow-on Biologics Players
    7.1 Sandoz
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Pfizer
    7.3 Teva Pahrmaceutical
    7.4 Celltrion
    7.5 Biocon
    7.6 Amgen
    7.7 Samsung Biologics
    7.8 Mylan
    7.9 Dr. Reddy's Laboratories
    7.10 Stada Arzneimittel AG

Chapter 8 Upstream and Downstream Analysis of Follow-on Biologics
    8.1 Industrial Chain of Follow-on Biologics
    8.2 Upstream of Follow-on Biologics
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Follow-on Biologics
        8.3.1 Leading Distributors/Dealers of Follow-on Biologics
        8.3.2 Leading Consumers of Follow-on Biologics

Chapter 9 Development Trend of Follow-on Biologics (2018-2028)
    9.1 Global Follow-on Biologics Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Follow-on Biologics Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Follow-on Biologics Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Follow-on Biologics Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Follow-on Biologics Market Size Forecast by Sales Channel (2018-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification
List of Tables and Figures

    Figure Follow-on Biologics Example
    Figure Global Follow-on Biologics Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Follow-on Biologics Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Follow-on Biologics Sales Comparison by Type (2013-2028)
    Figure Global Follow-on Biologics Sales Comparison by Application (2013-2028)
    Figure Global Follow-on Biologics Sales Comparison by Sales Channel (2013-2028)
    Table Global Follow-on Biologics Sales by Player (2016-2018)
    Table Global Follow-on Biologics Sales Market Share by Player (2016-2018)
    Figure Global Follow-on Biologics Sales Market Share by Player in 2017
    Table Global Follow-on Biologics Revenue (Million $) by Player (2016-2018)
    Table Global Follow-on Biologics Revenue Market Share by Player (2016-2018)
    Figure Global Follow-on Biologics Revenue Market Share by Player in 2017
    Table Global Follow-on Biologics Average Price by Player (2016-2018)
    Figure Global Follow-on Biologics Average Price by Player in 2017
    Figure Global Follow-on Biologics Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global Follow-on Biologics Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Recombinant Non-glycosylated Proteins
    Figure Global Recombinant Non-glycosylated Proteins Sales and Growth Rate (2013-2018)
    Figure Example of Recombinant Glycosylated Proteins
    Figure Global Recombinant Glycosylated Proteins Sales and Growth Rate (2013-2018)
    Figure Example of Recombinant Peptides
    Figure Global Recombinant Peptides Sales and Growth Rate (2013-2018)
    Table Global Follow-on Biologics Sales by Type (2013-2018)
    Table Global Follow-on Biologics Sales Market Share by Type (2013-2018)
    Figure Global Follow-on Biologics Sales Market Share by Type in 2017
    Table Global Follow-on Biologics Revenue (Million $) by Type (2013-2018)
    Table Global Follow-on Biologics Revenue Market Share by Type (2013-2018)
    Figure Global Follow-on Biologics Revenue Market Share by Type in 2017
    Table Global Follow-on Biologics Average Price by Type (2013-2018)
    Figure Global Follow-on Biologics Average Price by Type in 2017
    Table Leading Players of Follow-on Biologics by Type in 2017
    Figure Example of Oncology
    Figure Global Follow-on Biologics for Oncology Sales and Growth Rate (2013-2018)
    Figure Example of Blood Disorders
    Figure Global Follow-on Biologics for Blood Disorders Sales and Growth Rate (2013-2018)
    Figure Example of Chronic Diseases
    Figure Global Follow-on Biologics for Chronic Diseases Sales and Growth Rate (2013-2018)
    Figure Example of Autoimmune Diseases
    Figure Global Follow-on Biologics for Autoimmune Diseases Sales and Growth Rate (2013-2018)
    Figure Example of Growth Hormone Deficiency
    Figure Global Follow-on Biologics for Growth Hormone Deficiency Sales and Growth Rate (2013-2018)
    Table Global Follow-on Biologics Sales by Application (2013-2018)
    Table Global Follow-on Biologics Sales Market Share by Application (2013-2018)
    Figure Global Follow-on Biologics Sales Market Share by Application in 2017
    Table Leading Consumers of Follow-on Biologics by Application in 2017
    Figure Example of Direct Channel
    Figure Global Follow-on Biologics for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Follow-on Biologics for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Follow-on Biologics Sales by Sales Channel (2013-2018)
    Table Global Follow-on Biologics Sales Market Share by Sales Channel (2013-2018)
    Figure Global Follow-on Biologics Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of Follow-on Biologics by Sales Channel in 2017
    Table Global Follow-on Biologics Market Size and CAGR by Region (2013-2028)
    Table Global Follow-on Biologics Sales by Region (2013-2018)
    Table Global Follow-on Biologics Sales Market Share by Region (2013-2018)
    Figure Global Follow-on Biologics Sales Market Share by Region in 2017
    Table Global Follow-on Biologics Revenue (Million $) by Region (2013-2018)
    Table Global Follow-on Biologics Revenue Market Share by Region (2013-2018)
    Figure Global Follow-on Biologics Revenue Market Share by Region in 2017
    Table North America Follow-on Biologics Sales by Country (2013-2018)
    Figure North America Follow-on Biologics Sales Market Share by Country (2013-2018)
    Table North America Follow-on Biologics Revenue by Country (2013-2018)
    Figure North America Follow-on Biologics Revenue Market Share by Country (2013-2018)
    Figure North America Follow-on Biologics Sales Market Share by Type in 2017
    Figure North America Follow-on Biologics Sales Market Share by Application in 2017
    Figure United States Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure United States Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Canada Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Mexico Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Follow-on Biologics Sales by Country (2013-2018)
    Figure Europe Follow-on Biologics Sales Market Share by Country (2013-2018)
    Table Europe Follow-on Biologics Revenue by Country (2013-2018)
    Figure Europe Follow-on Biologics Revenue Market Share by Country (2013-2018)
    Figure Europe Follow-on Biologics Sales Market Share by Type in 2017
    Figure Europe Follow-on Biologics Sales Market Share by Application in 2017
    Figure Germany Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Germany Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure UK Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure France Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Italy Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Russia Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Spain Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Follow-on Biologics Sales by Country (2013-2018)
    Figure Asia-Pacific Follow-on Biologics Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Follow-on Biologics Revenue by Country (2013-2018)
    Figure Asia-Pacific Follow-on Biologics Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Follow-on Biologics Sales Market Share by Type in 2017
    Figure Asia-Pacific Follow-on Biologics Sales Market Share by Application in 2017
    Figure China Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure China Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Japan Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Korea Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure India Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Australia Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Follow-on Biologics Sales by Country (2013-2018)
    Figure South America Follow-on Biologics Sales Market Share by Country (2013-2018)
    Table South America Follow-on Biologics Revenue by Country (2013-2018)
    Figure South America Follow-on Biologics Revenue Market Share by Country (2013-2018)
    Figure South America Follow-on Biologics Sales Market Share by Type in 2017
    Figure South America Follow-on Biologics Sales Market Share by Application in 2017
    Figure Brazil Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Brazil Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Argentina Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Colombia Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Chile Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Follow-on Biologics Sales by Country (2013-2018)
    Figure Middle East & Africa Follow-on Biologics Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Follow-on Biologics Revenue by Country (2013-2018)
    Figure Middle East & Africa Follow-on Biologics Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Follow-on Biologics Sales Market Share by Type in 2017
    Figure Middle East & Africa Follow-on Biologics Sales Market Share by Application in 2017
    Figure Egypt Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Egypt Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure South Africa Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Follow-on Biologics Sales and Growth Rate (2013-2018)
    Figure Nigeria Follow-on Biologics Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Sandoz
    Table Follow-on Biologics Introduction of Sandoz
    Table Follow-on Biologics Sales, Price, Revenue, Gross Margin and Market Share of Sandoz (2016-2018)
    Table Industrial Chain of Follow-on Biologics
    Table Manufacturing Cost Structure of Follow-on Biologics
    Table General Manufacturing Process of Follow-on Biologics
    Table Leading Distributors/Dealers of Follow-on Biologics
    Table Leading Consumers of Follow-on Biologics
    Figure Global Follow-on Biologics Sales and Growth Rate Forecast (2018-2028)
    Figure Global Follow-on Biologics Revenue and Growth Rate Forecast (2018-2028)
    Table Global Follow-on Biologics Market Size and CAGR Forecast by Region (2018-2028)
    Table Global Follow-on Biologics Market Size and CAGR Forecast by Type (2018-2028)
    Table Global Follow-on Biologics Market Size and CAGR Forecast by Application (2018-2028)
    Table Global Follow-on Biologics Market Size and CAGR Forecast by Sales Channel (2018-2028) 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2500
Multi User - US $5000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify